The APS with chitosan provided reduced allergic symptoms, eosinophils infiltration, and expression of IL-4, indicating excellent potential for the treatment of allergic rhinitis [59] Xu et al. [60] investigated the potential of APS on inflammatory pathways to treat symptoms of allergic rhinitis. The gene discussed is IL4; the disease is allergic rhinitis.